Ó£»¨ÊÓƵ

Skip to main content
Fig. 3 | Ó£»¨ÊÓƵ

Fig. 3

From: The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in Ethiopia

Fig. 3

Cumulative incidence and trends of MTCT with 95% CI among HIV-exposed birth cohorts from 2017–2022 in selected hospitals in Ethiopia. Figure 3a–c shows cumulative incidence and trends of MTCT with 95% Confidence Intervals among 2017–2022 birth cohorts in selected Hospitals in Ethiopia ; 3a) Perinatal MTCT (N = 2521), 3b) Breastfeeding MTCT (N = 2281), and 3c) end of care MTCT (N = 2311)

Back to article page